article thumbnail

Can You Boost Your Immune System with Extra Zinc?

The People's Pharmacy

Most people would like to improve their immune function at this time of year. Extra Zinc and Immunity: Zinc is one of those minerals that gets very little respect. Extra Zinc and Immunity: Zinc is one of those minerals that gets very little respect. Yet this mineral is crucial for the immune system. Could extra zinc help?

article thumbnail

AC Immune poleaxed on Alzheimer’s study fail

pharmaphorum

Shares in AC Immune have collapsed after partner Genentech revealed its tau-targeting Alzheimer’s drug semorinemab had flunked a phase 2 trial in Alzheimer’s disease (AD). The post AC Immune poleaxed on Alzheimer’s study fail appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Intratumoural viral delivery improves glioblastoma survival

European Pharmaceutical Review

The viral therapy “aims to awaken the patient’s immune system and trigger a healing from within,” Dr Fueyo commented. After injection, patients that respond well develop inflammation inside the tumour, triggering an immune response that first kills the virus.” This makes it difficult to treat the cancer with immunotherapy.

article thumbnail

Opinion: The window is closing to stop deadly drug-resistant fungi like Candida auris

STAT

Clinical cases have risen each year since it was first publicly reported in 2016, with 2,377 reported in 2022, and the CDC notes that based on limited information, 30–60% of those infected with C. auris infects people whose immune systems are already weakened due to other health issues. Twenty-seven states and Washington, D.C.

article thumbnail

Will Novartis provide new oral option for chronic hives?

European Pharmaceutical Review

While injectable biologic therapies are an effective option for CSU that is uncontrolled by these drugs, less than 20 percent of patients worldwide are treated with them, according to a 2016 British Journal of Dermatology paper and research shared by Novartis. In REMIX-2, the clinical trial enrolled 455 participants with CSU.

article thumbnail

German biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapy

pharmaphorum

Founded in 2016 as a spin-out from Wuerzburg University, CatalYm’s lead molecule CTL-002 is designed to neutralise the tumour-produced protein GDF-15. High concentrations of the GDF-15 in serum and tumour-micro-environment help cancers to evade the immune system and are associated with resistance to current therapies.

article thumbnail

Early data back J&J and AC Immune’s Alzheimer’s jab

pharmaphorum

Shares in Swiss biotech AC Immune have risen sharply after it said a vaccine in development for Alzheimer’s disease (AD) hit the mark in a phase 1/2 trial. . The vaccine stimulated antibodies against the protein in all 32 patients with early-stage AD in the study at levels that AC Immune thinks should have a therapeutic effect.